Come up with a name for your new list and we'll add to it:
CyDex Pharmaceuticals raised a round of funding on , . Investors include
Kansas Technology Enterprise Corporation.
CyDex Pharmaceuticals develops drugs specifically designed to address limitations of current therapies for conditions such as bipolar disorder, schizophrenia, fungus, and canine motion sickness.…